Page last updated: 2024-08-24

topotecan and dx 52-1

topotecan has been researched along with dx 52-1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, LM; Cowen, RL; Debray, C; Erler, JT; Eustace, A; Parker, CA; Sheppard, FC; Stratford, IJ; Williams, KJ1

Other Studies

1 other study(ies) available for topotecan and dx 52-1

ArticleYear
Reversing hypoxic cell chemoresistance in vitro using genetic and small molecule approaches targeting hypoxia inducible factor-1.
    Molecular pharmacology, 2006, Volume: 69, Issue:2

    Topics: Adenoviridae; Antineoplastic Agents, Phytogenic; Cell Hypoxia; Cell Line, Tumor; Cell Nucleus; Drug Resistance, Neoplasm; Etoposide; Genetic Vectors; Green Fluorescent Proteins; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Isoquinolines; Neoplasms; Oxygen; Sequence Deletion; Topotecan; Transcriptional Activation

2006